Embla Medical hf. (CPH:EMBLA)

Market Cap	12.90B
Revenue (ttm)	5.55B
Net Income (ttm)	464.57M
Shares Out	425.84M
EPS (ttm)	1.09
PE Ratio	27.72
Forward PE	22.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,757
Average Volume	31,101
Open	30.20
Previous Close	31.20
Day's Range	30.20 - 31.70
52-Week Range	25.01 - 38.00
Beta	0.59
RSI	36.70
Earnings Date	Jul 22, 2025

About DFS

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 4,061
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: EMBLA

Financial Performance

In 2024, Embla Medical's revenue was $854.89 million, an increase of 8.81% compared to the previous year's $785.68 million. Earnings were $68.28 million, an increase of 16.94%.

Financial numbers in GBP